Zain Khalpey: Left Atrial Appendage Closure vs Oral Anticoagulation in Atrial Fibrillation
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared a post on LinkedIn about a recent article by Paschalis Karakasis, published in EP Europace, adding:
“Left Atrial Appendage Closure vs Oral Anticoagulation in Atrial Fibrillation.
A meta analysis of six randomized trials involving more than 7,000 patients compared left atrial appendage closure with oral anticoagulation for stroke prevention in atrial fibrillation.
LAAC was associated with fewer nonprocedural clinically relevant bleeding events, but a higher risk of ischemic stroke or systemic embolism.
There were no significant differences in overall stroke, major bleeding, hemorrhagic stroke, or mortality.
The findings suggest that LAAC should not be viewed as an equal replacement for anticoagulation in every patient.
Its role remains most relevant for carefully selected individuals who cannot tolerate long-term anticoagulation or have significant bleeding concerns.”
Title: Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials
Authors: Paschalis Karakasis, Stylianos Tzeis, Athanasios Samaras, Konstantinos Vlachos, Konstantinos Pamporis, Panagiotis Theofilis, Apostolos Tzikas, Antonios P Antoniadis, Pierre Jaïs, Nikolaos Fragakis
Stay udpated on all scientific advances with Hemostasis Today.
-
Nov 4, 2026, 18:57Connecting Haemophilia Centres, Certifying Treaters, and Improving National Data in Romania – EHC
-
Nov 4, 2026, 18:45Smitirupa Mishra: A Practical Guide to Coagulation Pathway Assessment and Laboratory Interpretation
-
Nov 4, 2026, 15:59Alessandra Bosch: A Successful Patient Day for the Bleeding Disorders Community in Zürich
-
Nov 4, 2026, 15:47Wolfgang Miesbach: Targeting Hepatic Endothelial Cells for Lentiviral Gene Therapy in Haemophilia A
-
Nov 4, 2026, 15:20Augustina Isioma Ikusemoro: Before You Transfuse, Think PBM
-
Nov 4, 2026, 14:23Advancing Hemophilia Care Through Global Research – WFH
-
Nov 4, 2026, 14:12Jean-Jacques Kiladjian: From JAK Inhibitor-Associated Skin Cancers to Laboratory Discovery
-
Nov 4, 2026, 13:59Rita Li: ASH 2026 Abstract Achievement Award for Gut Microbiome Research
-
Nov 4, 2026, 13:38Omid Seidizadeh: Improving Access to von Willebrand Disease Diagnosis and Treatment Across Europe